| Unique ID issued by UMIN | UMIN000019076 |
|---|---|
| Receipt number | R000022003 |
| Scientific Title | A study for evaluating the effect of the intake of a resistant glucan (water-soluble dietary fiber) on postprandial hyperglycemia : randomized, placebo-controlled, double blind cross-over trial |
| Date of disclosure of the study information | 2015/09/19 |
| Last modified on | 2016/06/27 10:02:29 |
A study for evaluating the effect of the intake of a resistant glucan (water-soluble dietary fiber) on postprandial hyperglycemia : randomized, placebo-controlled, double blind cross-over trial
A study for evaluating the effect of the intake of a resistant glucan (water-soluble dietary fiber)
A study for evaluating the effect of the intake of a resistant glucan (water-soluble dietary fiber) on postprandial hyperglycemia : randomized, placebo-controlled, double blind cross-over trial
A study for evaluating the effect of the intake of a resistant glucan (water-soluble dietary fiber)
| Japan |
Healthy adult
| Adult |
Others
NO
To investigate the effect of a resistant glucan on postprandial hyperglycemia
Efficacy
area under the curve of plasma glucose
Postprandial blood glucose, maximum plasma glucose level, insulin
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
| Food |
test food with resistant glucan (single ingestion) - washout period - placebo food without resistant glucan (single ingestion)
placebo food without resistant glucan (single ingestion) - washout period - test food with resistant glucan (single ingestion)
| 20 | years-old | <= |
| 64 | years-old | >= |
Male and Female
1) Males and females from 20 to 64 years of age
2) Subjects falling under any of the following
A. fasting blood glucose levels are ranged 110 to 125 mg/dL
B. postprandial blood glucose levels are ranged from 140 mg/dL to 199 mg/dL
1) Subjects who routinely use food rich in dietary fiber
2) Subjects routinely taking medicine or health food which may influence glucose metabolism
3) Subjects who has under treatment or a history of serious disease(e.g., diabetes, liver disease, kidney disease, or heart disease)
4) Subjects having possibilities for emerging allergy related to the study
5) Subjects who are under medication or having a history of serious diseases for which medication was required
6) Subjects who have fasting blood glucose more than 126 mg/dL on preliminary examination
7) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination
8) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study
9) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating
10) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire
11) Subjects judged as unsuitable for the study by the investigator for other reasons
60
| 1st name | |
| Middle name | |
| Last name | Toshihiro Yamamoto |
NIHON SHOKUHIN KAKO CO., LTD.
RESEARCH INSTITUTE
30 TAJIMA FUJI, SHIZUOKA
0545-53-5995
toshihiro.yamamoto@nisshoku.co.jp
| 1st name | |
| Middle name | |
| Last name | Hiroyasu Shimada |
TTC Co., Ltd.
Clinical Research Planning Department
1-20-2, Ebisunishi, Shibuya-ku, Tokyo
03-5459-5329
h.shimada@ttc-tokyo.co.jp
TTC Co., Ltd
NIHON SHOKUHIN KAKO CO., LTD.
Profit organization
NO
| 2015 | Year | 09 | Month | 19 | Day |
Unpublished
Completed
| 2015 | Year | 08 | Month | 27 | Day |
| 2015 | Year | 09 | Month | 20 | Day |
| 2015 | Year | 09 | Month | 19 | Day |
| 2016 | Year | 06 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022003